68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer
Status:
Recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
To evaluate the potential usefulness of 68Ga-PSMA-11 positron emission tomography/computed
tomography (PET/CT) for the diagnosis of primary and metastatic lesions, efficacy assessment
and recurrence monitoring in various types of cancer.
Phase:
Early Phase 1
Details
Lead Sponsor:
First Affiliated Hospital of Fujian Medical University